Skip to content
Search

Latest Stories

RPS and Pharmacist Support host roundtable to explore actions needed to support staff

The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable on the impact of pharmacy workforce wellbeing on patient safety on Wednesday (17 May).

It also released its annual Workforce Wellbeing Survey which showed continued pressures on pharmacy teams.


The discussion explored the actions needed to support staff so they can continue providing safe and effective patient care and included representatives from the NHS, professional bodies, employers, trade unions, education and regulators.

A report of the roundtable will be published in the summer.

Amandeep Doll, RPS Head of Professional Belonging, said: “We know that pharmacy teams go above and beyond for their patients, but are also under enormous pressure.

“Now more than ever, we need to strive to make the pharmacy profession more inclusive and ensure that everyone’s wellbeing is supported.

“It is vital that we do all we can to encourage people into pharmacy and to support them so they can enhance their skills, develop their careers, and continue to deliver high-quality patient care.

“This discussion was a welcome step and showed that making a difference for staff wellbeing requires a concerted effort from stakeholders across the whole of pharmacy.

“RPS will produce a report of the discussion and as a group we have committed to meeting again in six months.”

In a joint statement RPS commented: “Pharmacy organisations, regulators, unions and employers heard about the well recognised correlations between the wellness and wellbeing of students, academics and the clinical workforce and the impact that this has on workforce effectiveness, patient safety and patient outcomes.

With continued pressure on pharmacy teams and the health service, it is more important than ever to work together so that patients can continue to access to high-quality, adequately staffed and safe pharmacy services.

Prioritising staff wellbeing and leadership within systems supports higher-quality and safer patient care and improves workforce retention.

The collaborative roundtable discussion highlighted the importance of supporting pharmacy teams across all sectors of practice to deliver patient care through healthy working environments, access to appropriate rest breaks, and opportunities for professional development.

Staff should feel empowered to use their professional judgement in the interests of patients and the public. Staff must also be given the support, training, and supervision they need to help enable them to complete their professional duties.

Solutions to the challenges facing workforce well-being require interventions that go beyond the individual. Making the health service a better place to work must be a shared endeavour so that we can continue to meet the needs of our patients and support our pharmacy people.”

The statement was supported by Association of Pharmacy Technicians, UK (APTUK); British Pharmaceutical Students Association (BPSA);  Care Quality Commission (CQC);  General Pharmaceutical Council (GPhC); Guild of Healthcare Pharmacists (GHP); National Pharmacy Association (NPA); Pharmacists Defence Association (PDA); Pharmacy School Council (PhSC); Community Pharmacy England (CPE); Pharmacist Support; and Royal Pharmaceutical Society (RPS).

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less